Product Monograph · Minerals & Essential Nutrients
Ferrochel® Iron
Not all iron supplements are the same. This one starts with the form.
Position in range · Iron Repletion & Energy Support
Iron remains one of the most commonly supplemented minerals in clinical practice, yet many patients struggle with traditional iron products due to digestive discomfort and poor compliance. When patients have stopped iron before — and many have — the form is almost always the reason.
Ferrochel® Iron uses the original patented ferrous bisglycinate chelate from Albion Laboratories — selected for absorption profile, digestive tolerability and quality documentation. The goal is simple: help patients stay on the iron they actually need.
Where Ferrochel® Iron sits in the Minerals & Essential Nutrients range
Ferrochel® Iron
“I don’t feel as robust as I should.”
MagOrigin
“I feel wired, tense and depleted.”
ZinCore
“I seem to pick up everything.”
MetaboOrigin
“I crash if I don’t eat.”
Consider when
- Iron status support is indicated
- Ferritin or iron markers are being monitored
- Energy and resilience support are part of the picture
- Women’s health protocols require iron support
- Exercise recovery and oxygen transport are relevant
- Traditional iron products have been poorly tolerated
- Long-term compliance is a clinical consideration
Common combinations
Clinical Pearl
The single most important clinical conversation when prescribing iron is compliance. Many patients have stopped iron before — constipation, nausea and metallic taste are the most common reasons. When a patient says they have tried iron and could not continue, the form was almost certainly the problem. Ferrochel®’s tolerability profile changes that conversation.
Patient Voice
When Patients Say…
Iron insufficiency presents subtly — patients rarely describe it in those terms. They describe its consequences. These statements consistently point toward the picture.
I don’t feel as robust as I should.
I feel tired even when I sleep well.
I get breathless more easily than I used to.
My energy doesn’t match my age.
I struggle to recover after exercise.
I feel flat and depleted.
I’ve stopped iron before because it upset my stomach.
I just don’t have the resilience I used to.
Patient Presentations
When Ferrochel® Iron Commonly Comes to Mind
The following presentations most consistently point toward iron as a relevant clinical consideration — and Ferrochel® specifically where tolerability and compliance are part of the clinical picture.
Overview
Product Overview
Ferrochel® Iron uses the original patented ferrous bisglycinate chelate from Albion Laboratories — providing 29mg elemental iron per capsule in the form with the best-documented combination of absorption and tolerability in the iron supplement category.
The clinical rationale is simple: iron supplementation only works if the patient takes it consistently. The form of iron is the single most important determinant of whether that happens. Ferrous sulphate — the standard pharmaceutical iron — has a well-documented profile of gastrointestinal side effects that lead to high discontinuation rates. Ferrochel® bisglycinate chelate absorbs through amino acid transporters rather than ionic mineral channels, reducing the free iron exposure in the gastrointestinal lumen that drives most iron-related digestive complaints.
At 29mg elemental iron per capsule, Ferrochel® Iron provides a clinically meaningful dose consistent with therapeutic iron supplementation guidelines, in a form patients can take consistently.
Practitioner Rationale
Why Practitioners Choose Ferrochel® Iron
Better form. Better tolerability. Better compliance. Better practitioner confidence. These are the four reasons Ferrochel® earns its place in the practitioner dispensary over standard iron products.
Ferrochel® — The Original Patented Form
Ferrochel® is the original patented ferrous bisglycinate chelate from Albion Laboratories — the standard against which other chelated iron forms are measured. Not a generic bisglycinate. A specific, documented, quality-assured form with its own research history.
Better Tolerability
The chelated form significantly reduces free iron exposure in the gastrointestinal tract — the primary cause of the constipation, nausea and discomfort that cause most patients to discontinue traditional iron. Patients who have previously been unable to tolerate iron frequently manage Ferrochel® without complaint.
Better Compliance
A product patients can take consistently is a more effective clinical tool than a more potent product they abandon. The form choice is a compliance choice — and in iron supplementation, compliance is the clinical variable that determines outcome.
Chelated Mineral Technology with CoA
Bisglycinate chelate technology protects the iron through the gastrointestinal environment and supports efficient intestinal uptake. Each batch carries a Certificate of Analysis verifying elemental iron content and purity.
Clinical Context
Iron Forms — Why Form Matters
The form of iron determines both its absorption and its tolerability profile. For many practitioners, keeping patients on iron consistently is often more important than selecting the cheapest iron available.
| Form | Absorption | Tolerability | Clinical Notes |
|---|---|---|---|
| Ferrochel® Bisglycinate This product | High | Well tolerated — significantly reduced GI side effects | Preferred where GI tolerability and compliance are clinical priorities. Absorbs through amino acid transporters, reducing free iron exposure. Research: Layrisse et al. (2000); Schümann et al. (2014). |
| Ferrous Sulphate | Moderate | Commonly associated with constipation, nausea and abdominal discomfort | Standard pharmaceutical form. High rate of GI side effects leads to significant discontinuation. The most common reason practitioners see patients who have stopped iron. |
| Ferrous Fumarate | Moderate to good | Better than sulphate; tolerance varies between patients | Common consumer supplement form. More tolerable than sulphate but still associated with GI complaints at therapeutic doses in sensitive individuals. |
| Ferrous Gluconate | Moderate | Generally mild; lower elemental iron per dose | Lower elemental iron content per unit weight requires larger doses to achieve therapeutic amounts. Less commonly used in practitioner protocols. |
Clinical Applications
Common Uses in Practice
Practitioners may consider Ferrochel® Iron where one or more of the following support areas are clinically relevant. All use should be guided by individual practitioner assessment and appropriate iron status testing.
Iron status support
Ferritin support protocols
Energy & vitality support
Women’s health support
Exercise recovery support
Nutritional resilience support
Formulation Detail
Ingredient Detail
Full practitioner detail on the Ferrochel® ferrous bisglycinate chelate, elemental iron content, and quality specification.
Form, absorption and tolerability
Ferrochel® ferrous bisglycinate is iron chelated to two glycine molecules in a stable ring structure. The chelate is absorbed intact through intestinal amino acid transporters — specifically the dipeptide transport pathway — rather than through the ionic mineral transport channels used by ferrous sulphate and other inorganic iron forms.
This transport difference has two clinical consequences: first, the chelated iron is absorbed more efficiently per unit dose; second, because the iron remains chelated rather than free in the gastrointestinal lumen, it does not generate the reactive oxygen species and intestinal irritation that drive the constipation, nausea, and abdominal discomfort associated with ferrous sulphate. Research by Layrisse et al. (2000) and Schümann et al. (2014) has investigated the absorption and tolerability profile of ferrous bisglycinate chelate in clinical populations.
Clinical dose and oxygen transport
At 29mg elemental iron per capsule, Ferrochel® Iron provides a therapeutically meaningful dose. The adult RDA for iron is 8mg for men and 18mg for women of reproductive age — rising to 27mg in pregnancy. Therapeutic supplementation for iron insufficiency typically uses 25–100mg elemental iron daily depending on severity and individual response.
Iron’s primary physiological role is in haemoglobin synthesis — the protein responsible for oxygen transport in red blood cells — and in myoglobin in muscle tissue. It is also a required component of the mitochondrial cytochromes involved in cellular energy production. These two roles explain why iron insufficiency presents as fatigue, reduced exercise capacity, and impaired recovery alongside any oxygen-transport related symptoms.
Clinical Observations
Clinical Notes from Practice
The following observations reflect patterns seen in clinical practice and are offered to support practitioner decision-making. They are not intended as outcome claims.
When a patient says they have tried iron before and stopped, always ask about the form. In the majority of cases it will have been ferrous sulphate — the standard pharmaceutical prescription. The digestive side effects are not imagined and not a reason to avoid iron; they are a reason to change the form. Ferrochel® changes the conversation from “iron is difficult” to “that form was difficult.”
Ferritin is the most clinically useful iron status marker for functional insufficiency. Serum iron and haemoglobin remain in normal range well into iron insufficiency. A ferritin of 15–20 ng/mL is within most laboratory reference ranges but is functionally inadequate for many patients. Practitioners should use functional ferritin targets — many use 50–80 ng/mL as a functional minimum — rather than laboratory lower limits of normal.
Spacing Ferrochel® away from calcium supplements, coffee, and tea is worth advising at the point of prescription. Calcium directly competes with iron for intestinal transport. Coffee and tea contain tannins and chlorogenic acid that inhibit non-haem iron absorption significantly. These interactions affect even well-absorbed forms. Practical timing guidance — morning away from breakfast coffee and dairy — makes a real clinical difference to outcome.
Vitamin C co-administration increases non-haem iron absorption by reducing ferric iron to the more absorbable ferrous form and preventing formation of insoluble iron complexes. Even the bisglycinate chelate benefits from vitamin C co-administration — taking Ferrochel® with a vitamin C-containing food or supplement is a practical recommendation that improves outcome without complexity.
In female athletes and women with heavy periods, iron monitoring should be routine. Both groups have significantly elevated iron requirements that dietary intake rarely meets consistently. For these patients, Ferrochel® as a long-term maintenance supplement — once iron stores are restored — is appropriate and practical given its tolerability profile.
Protocol Support
Common Combinations Within the Point of Origin Range
Individual assessment should always guide prescribing decisions. Note spacing requirements: take Ferrochel® at least 2 hours from MagOrigin and ZinCore to avoid mineral absorption competition.
Dosing Guidance
Suggested Use
| Approach | Suggested Dose | Notes |
|---|---|---|
| Maintenance support | 1 capsule daily with food | 29mg elemental iron. Suitable for maintenance, prevention of recurrence, and ongoing support in at-risk populations |
| Active repletion | As directed by treating practitioner | Dose may be increased for active iron repletion — always guided by iron status testing and clinical assessment |
| Vitamin C support | Take with vitamin C-rich food or supplement | Vitamin C enhances non-haem iron absorption by maintaining iron in the ferrous state and preventing inhibitory complexes |
| Spacing | 2 hours from calcium, coffee and tea | Calcium competes with iron for absorption; tannins in coffee and tea inhibit iron uptake. Morning use before breakfast coffee is a practical approach. |
Iron supplementation should be guided by baseline and follow-up testing of ferritin and relevant iron markers. Do not supplement long-term without monitoring iron status.
Safety
Contraindications & Cautions
Haemochromatosis and Iron Overload — Critical
Iron supplementation is absolutely contraindicated in haemochromatosis (hereditary iron overload disorder) and in any condition associated with iron overload. Iron accumulates in tissues and causes organ damage in these conditions — supplementation can accelerate this process. Practitioners must screen for haemochromatosis history before prescribing iron supplements and must not recommend iron supplementation without knowing the patient’s iron status.
Test Before Supplementing Long-Term
Iron supplementation should be based on documented iron status — ferritin, serum iron, transferrin saturation, and/or full blood count. Long-term iron supplementation without monitoring is inappropriate clinical practice. Iron stores can become elevated with prolonged supplementation even in patients who were initially insufficient. Periodic monitoring — at least every 3–6 months during active supplementation — is appropriate.
Medication Interactions
Iron significantly reduces the absorption of several important medication classes when taken simultaneously: tetracycline and fluoroquinolone antibiotics, levodopa, methyldopa, levothyroxine, and some antacids. Practitioners should advise spacing Ferrochel® by at least 2–4 hours from these medications, or take iron at a time of day well separated from medication dosing.
Pregnancy and Breastfeeding
Iron requirements increase significantly in pregnancy. Ferrochel® Iron may be appropriate during pregnancy to support elevated iron demands — however, dose selection during pregnancy should be guided by iron status testing and an appropriately qualified healthcare professional. Not all supplemental iron forms or doses are appropriate in all pregnancy contexts.
Keep Out of Reach of Children
Iron supplements are a leading cause of accidental poisoning in young children. Ferrochel® Iron must be kept securely out of reach of children. Even single adult doses can be toxic to small children.
Practitioner Questions
Frequently Asked Questions
Which patient would I reach for Ferrochel® Iron for?
The patient who doesn’t feel as robust as they should. Who is tired despite adequate sleep. Who lacks the resilience and stamina they used to have. Who has stopped iron previously because it caused digestive problems. Who has low or low-normal ferritin. Women with menstrual losses, athletes with high training loads, vegetarians and vegans, and patients recovering from illness or surgery are the most common clinical populations.
Why Ferrochel® specifically rather than other bisglycinate products?
Ferrochel® is the original patented ferrous bisglycinate chelate from Albion Laboratories — the form on which the bisglycinate category’s research base was built. Other products labelled “bisglycinate” may use different production methodologies and quality specifications. When citing the research basis for bisglycinate iron — including Layrisse et al. (2000) and Schümann et al. (2014) — that research is on Ferrochel® specifically. The trademark is not just a brand name; it is a quality and methodology specification.
My patient’s haemoglobin is normal. Is iron supplementation still relevant?
Yes — where ferritin is low or low-normal. Haemoglobin falls late in iron insufficiency; ferritin falls first. The symptomatic presentation of iron insufficiency — fatigue, reduced exercise tolerance, poor recovery, flat mood — occurs well before haemoglobin is affected. Functional ferritin targets (50–80 ng/mL is commonly used in practice) are more clinically relevant than laboratory lower limits of normal for assessing iron status in symptomatic patients.
Can Ferrochel® be taken with other minerals?
With timing considerations. Iron competes significantly with zinc and moderately with magnesium for intestinal absorption — they should be taken at separate times of day, at least 2 hours apart. Ferrochel® does not compete significantly with calcium supplements when taken as the bisglycinate chelate form (unlike inorganic iron), but spacing from high-calcium meals and dairy is still prudent clinical advice.
Should I test iron levels before recommending this product?
Yes — for long-term supplementation, testing is non-negotiable. At minimum, a baseline ferritin. Ideally a full iron panel including serum iron, transferrin saturation, and ferritin. This both confirms that iron supplementation is appropriate (ruling out haemochromatosis and pre-existing iron overload) and provides a baseline for monitoring response. Testing every 3–6 months during active supplementation is appropriate clinical practice.
Quick Reference
Practitioner Summary
Reach for Ferrochel® Iron when:
- Iron status support is indicated and compliance matters
- The patient has previously stopped iron due to digestive side effects
- Ferritin is low or low-normal with an energy and resilience presentation
- Women’s health protocols require sustained iron support
- Athletic performance, exercise recovery and oxygen transport are relevant
- Dietary iron intake is insufficient and the form must maximise absorption
Frequently combined with
Ferrochel® Iron is for the patient who doesn’t feel as robust as they should. The original patented ferrous bisglycinate chelate — better form, better tolerability, better compliance. Test before supplementing. Monitor while supplementing. Choose the form that patients will actually continue taking.
Ferrochel® Iron is a practitioner-formulated nutritional support product. It is not intended to diagnose, treat, cure, or prevent disease. Individual suitability should be assessed by an appropriately qualified healthcare professional. Iron supplementation should be based on documented iron status — do not use long-term without testing. Ferrochel® is a registered trademark of Albion Laboratories. This resource is intended for professional education and product support only.